Yahoo Web Search

Search results

  1. Vanda Pharmaceuticals Inc. (VNDA) At close: May 24 at 4:00 PM EDT. 1D. 5D. 3M. 6M. YTD. 1Y. 5Y. All. Key Events. Mountain. Loading Chart for VNDA. 9/21 12:03 PM. Previous Close 4.91. Open...

    • Conversations

      Find the latest Vanda Pharmaceuticals Inc. (VNDA) stock...

    • Analysis

      See Vanda Pharmaceuticals Inc. (VNDA) stock analyst...

    • Sustainability

      See Vanda Pharmaceuticals Inc. (VNDA) Environment, Social...

    • Holders

      Find out the direct holders, institutional holders and...

    • Chart

      Interactive Chart for Vanda Pharmaceuticals Inc. (VNDA),...

    • Options

      View the basic VNDA option chain and compare options of...

    • Historical Data

      Discover historical prices for VNDA stock on Yahoo Finance....

  2. Stock rises on the news. Zacks • 9 days ago. VNDA. +6.52% LGNZZ. ANIP. Vanda Pharmaceuticals reports positive data from motion sickness trial. In the trial, only 10.4% and 18.3% of the subjects...

  3. People also ask

  4. 6 hours ago · Johnson & Johnson ( JNJ) has transferred ownership to Vanda Pharmaceuticals ( NASDAQ: VNDA) of the FDA new drug and investigational drug applications for the multiple sclerosis drug Ponvory, also ...

  5. 3 days ago · A high-level overview of Vanda Pharmaceuticals Inc. (VNDA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

  6. Get the latest Vanda Pharmaceuticals Inc. (VNDA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  7. Apr 17, 2024 · Wed, Apr 17, 2024, 6:30 AM 2 min read. Future Pak proposes to acquire 100% of the issued and outstanding shares of Vanda. Implies a premium of 79.0% to 91.4% to Vanda's closing price of...

  8. May 24, 2024 · Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results. Revenues for Q1 2024 were $47.5 million, an increase of 5% compared to Q4 2023 Cash increase of $5.9 million in Q1 2024 to $394.1 million Fanapt® approved for the acute treatment of bipolar I disorder... 21 days ago - PRNewsWire.

  1. People also search for